68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs)

NCT02359500 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

71

Enrollment

OTHER

Sponsor class

Stopped compound no longer available

Conditions

Neuroendocrine Tumors
Carcinoid Tumors

Interventions

DRUG: 68Ga-DOTATOC PET

Sponsor

Lale Kostakoglu